WuXi VIR Alnylam combo may be driving the share price this week. | ALNY Message Board Posts

Alnylam Pharmaceuticals

  ALNY website

ALNY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34839 of 34849  at  6/19/2020 7:37:47 PM  by

Steve_382


 In response to msg 34837 by  Steve_382
view thread

Re: WuXi VIR Alnylam combo may be driving the share price this week.

 Sorry for posting such a messy topic, but after reading the 8-K a little closer, I see that Alnylam is at least somewhat included.
 
 

On June 12, 2020, following the Company’s achievement of proof of concept for VIR-2218, Brii Bio notified the Company of the exercise of its option to obtain exclusive rights to develop and commercialize compounds and products arising from VIR-2218 in greater China. Brii Bio paid the Company a $20.0 million option exercise fee in  connection with the option exercise, half of which the Company will pay to Alnylam Pharmaceuticals, Inc. (“Alnylam”) in connection with the Company’s collaboration and license agreement with Alnylam.

 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 73
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
34841 Re: WuXi VIR Alnylam combo may be driving the share price this week. sherk 0 6/19/2020 7:43:36 PM






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...